Edwards Lifesciences (EW) Liabilities from Discontinued Operations (2023 - 2025)

Edwards Lifesciences has reported Liabilities from Discontinued Operations for 3 years, with the latest figure at 2300000.0 in Q3 2025.

• For the quarter ending Q3 2025, Liabilities from Discontinued Operations rose 27.78% year-over-year to 2300000.0; the trailing twelve-month figure through Sep 2025 stood at 2300000.0 (up 27.78% YoY), and the FY2024 full-year result was 2000000.0, down 92.03% from the prior year.
• Liabilities from Discontinued Operations for Q3 2025 stood at 2300000.0, roughly flat from 2300000.0 in the prior quarter.
• The five-year high for Liabilities from Discontinued Operations was 107200000.0 in Q2 2024, with the low at 1800000.0 in Q3 2024.
• Average Liabilities from Discontinued Operations over 3 years is 20428571.43, with a median of 2300000.0 recorded in 2025.
• Peak annual rise in Liabilities from Discontinued Operations reached 27.78% in 2025, while the deepest fall reached 97.85% in 2025.
• Tracing EW's Liabilities from Discontinued Operations over 3 years: stood at 25100000.0 in 2023, then plunged by 92.03% to 2000000.0 in 2024, then rose by 15.0% to 2300000.0 in 2025.
• The last three Liabilities from Discontinued Operations figures came in at 2300000.0 (Q3 2025), 2300000.0 (Q2 2025), and 2300000.0 (Q1 2025), per Business Quant data.

Peer Comparison